Fig. 1

Schematic diagram of the program consisting of multidrug pretransplant immune hematopoietic suppression therapy including courses of dexamethasone and fludarabine followed by a modified myeloablative conditioning regimen. The post-transplant GVHD prophylaxis consisted of CsA, MMF and short-term MTX. See Methods section for details